Kenneth Hughes
Chief Operating Officer at MICROBIX BIOSYSTEMS INC.
Net worth: 111 475 $ as of 2024-04-29
Profile
Kenneth Hughes is the founder of PlantForm Corp.
(founded in 2008) and Roker Biotechnologies, Inc. (founded in 2010).
He is currently the Chief Operating Officer at Microbix Biosystems, Inc. (since 2019).
Dr. Hughes was previously the President & Chief Executive Officer at Itp Biomedica Corp.
(from 2014 to 2019), Vice President-Scientific Affairs at Microbix Biosystems, Inc. (from 1995 to 2010), and Vice President-Scientific & Regulatory Affairs at Innovative Medicines Canada (from 2011 to 2013).
He also worked as a Research Scientist at Hemosol Corp.
Dr. Hughes received his doctorate degree from the University of London in 1990 and his undergraduate degree from The University of Sheffield.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
MICROBIX BIOSYSTEMS INC.
0.33% | 2024-02-22 | 455,000 ( 0.33% ) | 111 475 $ | 2024-04-29 |
Kenneth Hughes active positions
| Companies | Position | Start |
|---|---|---|
| MICROBIX BIOSYSTEMS INC. | Chief Operating Officer | 2019-06-02 |
| Roker Biotechnologies, Inc. | Founder | 2009-12-31 |
Former positions of Kenneth Hughes
| Companies | Position | End |
|---|---|---|
| Itp Biomedica Corp. | Chief Executive Officer | 2018-12-31 |
Innovative Medicines Canada
 Innovative Medicines Canada Miscellaneous Commercial ServicesCommercial Services Innovative Medicines Canada manufactures medical and toilet products. The company was founded on April 23, 1914 and is headquartered in Ottawa, Canada. | Chief Tech/Sci/R&D Officer | 2012-12-31 |
| MICROBIX BIOSYSTEMS INC. | Chief Tech/Sci/R&D Officer | 2009-12-31 |
PlantForm Corp.
 PlantForm Corp. Pharmaceuticals: MajorHealth Technology PlantForm Corp. engages in a biopharmaceutical company. It focuses on the development and production of ntibody and protein drugs using manufacturing platform. The firm’s vivoXPRESS technology uses genetically modified tobacco plants to produce biopharmaceuticals in fully contained greenhouse environments. The company was founded by J. Christopher Hall, Mark Goldberg, Don Stewart, and Ronald G. Hosking in 2008 and is headquartered in Toronto, Canada. | Founder | - |
Hemosol Corp. /Old/
 Hemosol Corp. /Old/ Pharmaceuticals: MajorHealth Technology Hemosol Inc. is an integrated biopharmaceutical company focused on the development of a portfolio of products based on human hemoglobin. | Corporate Officer/Principal | - |
Training of Kenneth Hughes
| The University of Sheffield | Undergraduate Degree |
| University of London | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| MICROBIX BIOSYSTEMS INC. | Health Technology |
| Private companies | 5 |
|---|---|
Hemosol Corp. /Old/
Hemosol Corp. /Old/ Pharmaceuticals: MajorHealth Technology Hemosol Inc. is an integrated biopharmaceutical company focused on the development of a portfolio of products based on human hemoglobin. | Health Technology |
| Itp Biomedica Corp. | |
Innovative Medicines Canada
Innovative Medicines Canada Miscellaneous Commercial ServicesCommercial Services Innovative Medicines Canada manufactures medical and toilet products. The company was founded on April 23, 1914 and is headquartered in Ottawa, Canada. | Commercial Services |
PlantForm Corp.
PlantForm Corp. Pharmaceuticals: MajorHealth Technology PlantForm Corp. engages in a biopharmaceutical company. It focuses on the development and production of ntibody and protein drugs using manufacturing platform. The firm’s vivoXPRESS technology uses genetically modified tobacco plants to produce biopharmaceuticals in fully contained greenhouse environments. The company was founded by J. Christopher Hall, Mark Goldberg, Don Stewart, and Ronald G. Hosking in 2008 and is headquartered in Toronto, Canada. | Health Technology |
| Roker Biotechnologies, Inc. |
- Stock Market
- Insiders
- Kenneth Hughes
